These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22416834)

  • 1. Comparison of statistical models adjusting for baseline in the analysis of parallel-group thorough QT/QTc studies.
    Sun GG; Quan H; Kringle R; Meng Z
    J Biopharm Stat; 2012; 22(3):438-62. PubMed ID: 22416834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials.
    Sethuraman V; Sun Q
    Pharm Stat; 2009; 8(2):113-24. PubMed ID: 18481273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient and robust analysis of covariance model for baseline adjustment in parallel-group thorough QT/QTc studies.
    Lu K
    Stat Med; 2013 Jun; 32(14):2406-18. PubMed ID: 22996035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of baseline measurement on the change from baseline in QTc intervals.
    Tian H; Natarajan J
    J Biopharm Stat; 2008; 18(3):542-52. PubMed ID: 18470762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for positive control activity in a thorough QTc study.
    Zhang J
    J Biopharm Stat; 2008; 18(3):517-28. PubMed ID: 18470760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical issues including design and sample size calculation in thorough QT/QTc studies.
    Zhang J; Machado SG
    J Biopharm Stat; 2008; 18(3):451-67. PubMed ID: 18470755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some unexamined aspects of analysis of covariance in pretest-posttest studies.
    Ganju J
    Biometrics; 2004 Sep; 60(3):829-33. PubMed ID: 15339308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation testing in thorough QT/QTc clinical trials.
    Tsong Y; Zhong J; Chen WJ
    J Biopharm Stat; 2008; 18(3):529-41. PubMed ID: 18470761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues of QT prolongation assessment based on linear concentration modeling.
    Tsong Y; Shen M; Zhong J; Zhang J
    J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient analysis of covariance model for crossover thorough QT studies with period-specific pre-dose baselines.
    Lu K
    Pharm Stat; 2014; 13(6):388-96. PubMed ID: 25283768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.
    Stylianou A; Roger J; Stephens K
    J Biopharm Stat; 2008; 18(3):502-16. PubMed ID: 18470759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient analysis of covariance model for crossover thorough QT studies with period-specific baseline days.
    Lu K
    Pharm Stat; 2013; 12(4):192-200. PubMed ID: 23625584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis methods for QT/QTc prolongation.
    Ma H; Smith B; Dmitrienko A
    J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations in thorough QT studies.
    Zhang L; Dmitrienko A; Luta G
    J Biopharm Stat; 2008; 18(3):468-82. PubMed ID: 18470756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
    Tsong Y; Zhong J
    J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical consideration in testing for assay sensitivity in a "thorough" QT study.
    Sethuraman V; Wu S; Wang J
    J Biopharm Stat; 2010 May; 20(3):641-53. PubMed ID: 20358442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.